Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Weekend Box Office Results
It was a busy box office this past weekend with several new movies in theaters. Cheddar news breaks it all down.
Load More